Serrano-Heras G - Search Results

1

Circulating DNA and Survival in Solid Tumors.

Ocaña A, Díez-González L, García-Olmo DC, Templeton AJ, Vera-Badillo F, José Escribano M, Serrano-Heras G, Corrales-Sánchez V, Seruga B, Andrés-Pretel F, Pandiella A, Amir E. Ocaña A, et al. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):399-406. doi: 10.1158/1055-9965.EPI-15-0893. Epub 2015 Nov 24. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26604269 Review.

2

NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice.

Serrano-Heras G, Domínguez-Berzosa C, Collantes E, Guadalajara H, García-Olmo D, García-Olmo DC. Serrano-Heras G, et al. Cancer Lett. 2012 Mar;316(1):85-90. doi: 10.1016/j.canlet.2011.10.028. Epub 2011 Oct 25. Cancer Lett. 2012. PMID: 22093615

3

Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer.

Cuenca-López MD, Serrano-Heras G, Montero JC, Corrales-Sánchez V, Gomez-Juarez M, Gascón-Escribano MJ, Morales JC, Voisin V, Núñez LE, Morís F, Bader GD, Pandiella A, Ocaña A. Cuenca-López MD, et al. Oncotarget. 2015 Sep 29;6(29):27923-37. doi: 10.18632/oncotarget.4736. Oncotarget. 2015. PMID: 26314846 Free PMC article.

4

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.

Serrano-Heras G, Cuenca-López MD, Montero JC, Corrales-Sanchez V, Morales JC, Núñez LE, Morís F, Pandiella A, Ocaña A. Serrano-Heras G, et al. Oncotarget. 2015 Oct 13;6(31):31272-83. doi: 10.18632/oncotarget.5211. Oncotarget. 2015. PMID: 26418718 Free PMC article. Clinical Trial.

5

In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment.

Pérez-Peña J, Serrano-Heras G, Montero JC, Corrales-Sánchez V, Pandiella A, Ocaña A. Pérez-Peña J, et al. Mol Cancer Ther. 2016 Aug;15(8):1823-33. doi: 10.1158/1535-7163.MCT-16-0004. Epub 2016 Jun 2. Mol Cancer Ther. 2016. PMID: 27256375

6

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors.

Nieto-Jiménez C, Alcaraz-Sanabria A, Pérez-Peña J, Corrales-Sánchez V, Serrano-Heras G, Galán-Moya EM, Serrano-Oviedo L, Montero JC, Burgos M, Llopis J, Pandiella A, Ocaña A. Nieto-Jiménez C, et al. Oncotarget. 2017 Mar 21;8(12):19478-19490. doi: 10.18632/oncotarget.14465. Oncotarget. 2017. PMID: 28061448 Free PMC article.

7

Involvement of N-methylpurine DNA glycosylase in resistance to temozolomide in patient-derived glioma cells.

Serrano-Heras G, Castro-Robles B, Romero-Sánchez CM, Carrión B, Barbella-Aponte R, Sandoval H, Segura T. Serrano-Heras G, et al. Sci Rep. 2020 Dec 17;10(1):22185. doi: 10.1038/s41598-020-78868-0. Sci Rep. 2020. PMID: 33335215 Free PMC article.

8

Real-time PCR detection chemistry.

Navarro E, Serrano-Heras G, Castaño MJ, Solera J. Navarro E, et al. Clin Chim Acta. 2015 Jan 15;439:231-50. doi: 10.1016/j.cca.2014.10.017. Epub 2014 Oct 22. Clin Chim Acta. 2015. PMID: 25451956 Review.

9

Compartmentalization of prokaryotic DNA replication.

Bravo A, Serrano-Heras G, Salas M. Bravo A, et al. FEMS Microbiol Rev. 2005 Jan;29(1):25-47. doi: 10.1016/j.femsre.2004.06.003. FEMS Microbiol Rev. 2005. PMID: 15652974 Free article. Review.

10

PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients.

Gallego-Fabrega C, Carrera C, Reny JL, Fontana P, Slowik A, Pera J, Pezzini A, Serrano-Heras G, Segura T, Bin Dukhyil AA, Martí-Fàbregas J, Muiño E, Cullell N, Montaner J, Krupinski J, Fernandez-Cadenas I. Gallego-Fabrega C, et al. Stroke. 2016 Jul;47(7):1926-9. doi: 10.1161/STROKEAHA.116.013340. Epub 2016 Jun 14. Stroke. 2016. PMID: 27301936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page